Crown Bioscience establishes co-operation with Chinese research centre

摘要

Drug discovery and development service company Crown Bioscience, Inc has established an agreement with the National Resource Center for Mutant Mice (NRCMM), based in Nanjing, China, focusing on the development of new experimental cancer models to advance translational medical research and the treatment of cancers.